APO Research
Talk to an analyst

APO RESEARCH · REPORT

Children Influenza Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Children Influenza Vaccine Industry Growth and Trends Forecast to 2032

29 December 2025108 pages

Choose your research edition.

Industry ResearchChildren Influenza Vaccine Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Children Influenza Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Children Influenza Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Children Influenza Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Children Influenza Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Children Influenza Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Children Influenza Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Children Influenza Vaccine include BCHT, CCBIO, CSL, Hulan Bio, KM Biologics, Sanofi Pasteur, Sinovac, Viatris and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Children Influenza Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Children Influenza Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Children Influenza Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Children Influenza Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Children Influenza Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Children Influenza Vaccine Market by Company

BCHT

CCBIO

CSL

Hulan Bio

KM Biologics

Sanofi Pasteur

Sinovac

Viatris

AstraZeneca

GSK

Jiangsu GDK

Children Influenza Vaccine Segment by Type

Nasal Spray

Injection

Children Influenza Vaccine Segment by Application

Public

Private

Children Influenza Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Children Influenza Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Children Influenza Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Children Influenza Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Children Influenza Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Children Influenza Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nasal Spray Table 2. Major Company of Injection Table 3. Global Children Influenza Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Children Influenza Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Children Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Children Influenza Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Children Influenza Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Children Influenza Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Children Influenza Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Children Influenza Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Children Influenza Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Children Influenza Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Children Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Children Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Children Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Children Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Children Influenza Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Children Influenza Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Children Influenza Vaccine Industry Trends Table 25. Children Influenza Vaccine Industry Drivers Table 26. Children Influenza Vaccine Industry Opportunities and Challenges Table 27. Children Influenza Vaccine Industry Restraints Table 28. Global Children Influenza Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Children Influenza Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Children Influenza Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Children Influenza Vaccine Sales Share by Company (2021-2026) Table 32. Global Children Influenza Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Children Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Children Influenza Vaccine Major Company Production Sites and Headquarters Table 35. Global Children Influenza Vaccine Company, Product Type & Application Table 36. Global Children Influenza Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Children Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Children Influenza Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Children Influenza Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Children Influenza Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Children Influenza Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Children Influenza Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Children Influenza Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Children Influenza Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Children Influenza Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Children Influenza Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Children Influenza Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Children Influenza Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Children Influenza Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Children Influenza Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Children Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Children Influenza Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Children Influenza Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Children Influenza Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Children Influenza Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Children Influenza Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Children Influenza Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Children Influenza Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Children Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Children Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Children Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Children Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Children Influenza Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Children Influenza Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. BCHT Company Information Table 72. BCHT Business Overview Table 73. BCHT Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. BCHT Children Influenza Vaccine Product Portfolio Table 75. BCHT Recent Development Table 76. CCBIO Company Information Table 77. CCBIO Business Overview Table 78. CCBIO Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. CCBIO Children Influenza Vaccine Product Portfolio Table 80. CCBIO Recent Development Table 81. CSL Company Information Table 82. CSL Business Overview Table 83. CSL Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. CSL Children Influenza Vaccine Product Portfolio Table 85. CSL Recent Development Table 86. Hulan Bio Company Information Table 87. Hulan Bio Business Overview Table 88. Hulan Bio Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hulan Bio Children Influenza Vaccine Product Portfolio Table 90. Hulan Bio Recent Development Table 91. KM Biologics Company Information Table 92. KM Biologics Business Overview Table 93. KM Biologics Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. KM Biologics Children Influenza Vaccine Product Portfolio Table 95. KM Biologics Recent Development Table 96. Sanofi Pasteur Company Information Table 97. Sanofi Pasteur Business Overview Table 98. Sanofi Pasteur Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Sanofi Pasteur Children Influenza Vaccine Product Portfolio Table 100. Sanofi Pasteur Recent Development Table 101. Sinovac Company Information Table 102. Sinovac Business Overview Table 103. Sinovac Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Sinovac Children Influenza Vaccine Product Portfolio Table 105. Sinovac Recent Development Table 106. Viatris Company Information Table 107. Viatris Business Overview Table 108. Viatris Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Viatris Children Influenza Vaccine Product Portfolio Table 110. Viatris Recent Development Table 111. AstraZeneca Company Information Table 112. AstraZeneca Business Overview Table 113. AstraZeneca Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. AstraZeneca Children Influenza Vaccine Product Portfolio Table 115. AstraZeneca Recent Development Table 116. GSK Company Information Table 117. GSK Business Overview Table 118. GSK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. GSK Children Influenza Vaccine Product Portfolio Table 120. GSK Recent Development Table 121. Jiangsu GDK Company Information Table 122. Jiangsu GDK Business Overview Table 123. Jiangsu GDK Children Influenza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jiangsu GDK Children Influenza Vaccine Product Portfolio Table 125. Jiangsu GDK Recent Development Table 126. North America Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 127. North America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 128. North America Children Influenza Vaccine Sales Market Share by Country (2021-2026) Table 129. North America Children Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 130. North America Children Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. North America Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Children Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Children Influenza Vaccine Market Share by Country (2021-2026) Table 134. North America Children Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Children Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 136. Europe Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. Europe Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 138. Europe Children Influenza Vaccine Sales Market Share by Country (2021-2026) Table 139. Europe Children Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. Europe Children Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Children Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Children Influenza Vaccine Market Share by Country (2021-2026) Table 144. Europe Children Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Children Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Asia-Pacific Children Influenza Vaccine Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Children Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Asia-Pacific Children Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Children Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Children Influenza Vaccine Market Share by Country (2021-2026) Table 154. Asia-Pacific Children Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Children Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 156. Latin America Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Latin America Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Latin America Children Influenza Vaccine Sales Market Share by Country (2021-2026) Table 159. Latin America Children Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Latin America Children Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Children Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Children Influenza Vaccine Market Share by Country (2021-2026) Table 164. Latin America Children Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Children Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Children Influenza Vaccine Sales by Country (2021-2026) & (K Units) Table 168. Middle East and Africa Children Influenza Vaccine Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Children Influenza Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Middle East and Africa Children Influenza Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Children Influenza Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Children Influenza Vaccine Market Share by Country (2021-2026) Table 174. Middle East and Africa Children Influenza Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Children Influenza Vaccine Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Children Influenza Vaccine Distributors List Table 179. Children Influenza Vaccine Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Children Influenza Vaccine Image Figure 2. Global Children Influenza Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Children Influenza Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Children Influenza Vaccine Sales (2021-2032) & (K Units) Figure 5. Nasal Spray Image Figure 6. Global Nasal Spray Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Children Influenza Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Children Influenza Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Children Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Children Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Children Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Children Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Children Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Children Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Children Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Children Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Children Influenza Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Children Influenza Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Children Influenza Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Image Figure 24. Global Public Sales YoY Growth (2021-2032) & (K Units) Figure 25. Private Image Figure 26. Global Private Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Children Influenza Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Children Influenza Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Children Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Children Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Children Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Children Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Children Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Children Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Children Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Children Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Children Influenza Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Children Influenza Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Children Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Children Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Children Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Children Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Children Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Children Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Children Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Children Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Children Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Children Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Children Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Children Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Children Influenza Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Children Influenza Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Children Influenza Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Children Influenza Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Children Influenza Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Children Influenza Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Injection
Applications
  • Public
  • Private
Companies covered
  • BCHT
  • CCBIO
  • CSL
  • Hulan Bio
  • KM Biologics
  • Sanofi Pasteur
  • Sinovac
  • Viatris
  • AstraZeneca
  • GSK
  • Jiangsu GDK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Children Influenza Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Children Influenza Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Children Influenza Vaccine Market by Type
  6. 1.3.1 Nasal Spray
  7. 1.3.2 Injection
  8. 1.4 Global Children Influenza Vaccine Market Size by Type
  9. 1.4.1 Global Children Influenza Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Children Influenza Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Children Influenza Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Children Influenza Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Children Influenza Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Children Influenza Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Children Influenza Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Children Influenza Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Children Influenza Vaccine Industry Trends
  2. 2.2 Children Influenza Vaccine Industry Drivers
  3. 2.3 Children Influenza Vaccine Industry Opportunities and Challenges
  4. 2.4 Children Influenza Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Children Influenza Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Children Influenza Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Children Influenza Vaccine Price (2021-2026)
  4. 3.4 Global Children Influenza Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Children Influenza Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Children Influenza Vaccine Company, Product Type & Application
  7. 3.7 Global Children Influenza Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Children Influenza Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Children Influenza Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Children Influenza Vaccine Tier 1, Tier 2, and Tier 3
4 Children Influenza Vaccine Regional Status and Outlook
  1. 4.1 Global Children Influenza Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Children Influenza Vaccine Historic Market Size by Region
  3. 4.2.1 Global Children Influenza Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Children Influenza Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Children Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Children Influenza Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Children Influenza Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Children Influenza Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Children Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Children Influenza Vaccine by Application
  1. 5.1 Children Influenza Vaccine Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Children Influenza Vaccine Market Size by Application
  5. 5.2.1 Global Children Influenza Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Children Influenza Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Children Influenza Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Children Influenza Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Children Influenza Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Children Influenza Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Children Influenza Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Children Influenza Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 BCHT
  2. 6.1.1 BCHT Company Information
  3. 6.1.2 BCHT Business Overview
  4. 6.1.3 BCHT Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 BCHT Children Influenza Vaccine Product Portfolio
  6. 6.1.5 BCHT Recent Developments
  7. 6.2 CCBIO
  8. 6.2.1 CCBIO Company Information
  9. 6.2.2 CCBIO Business Overview
  10. 6.2.3 CCBIO Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CCBIO Children Influenza Vaccine Product Portfolio
  12. 6.2.5 CCBIO Recent Developments
  13. 6.3 CSL
  14. 6.3.1 CSL Company Information
  15. 6.3.2 CSL Business Overview
  16. 6.3.3 CSL Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CSL Children Influenza Vaccine Product Portfolio
  18. 6.3.5 CSL Recent Developments
  19. 6.4 Hulan Bio
  20. 6.4.1 Hulan Bio Company Information
  21. 6.4.2 Hulan Bio Business Overview
  22. 6.4.3 Hulan Bio Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hulan Bio Children Influenza Vaccine Product Portfolio
  24. 6.4.5 Hulan Bio Recent Developments
  25. 6.5 KM Biologics
  26. 6.5.1 KM Biologics Company Information
  27. 6.5.2 KM Biologics Business Overview
  28. 6.5.3 KM Biologics Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 KM Biologics Children Influenza Vaccine Product Portfolio
  30. 6.5.5 KM Biologics Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Children Influenza Vaccine Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 Sinovac
  38. 6.7.1 Sinovac Company Information
  39. 6.7.2 Sinovac Business Overview
  40. 6.7.3 Sinovac Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sinovac Children Influenza Vaccine Product Portfolio
  42. 6.7.5 Sinovac Recent Developments
  43. 6.8 Viatris
  44. 6.8.1 Viatris Company Information
  45. 6.8.2 Viatris Business Overview
  46. 6.8.3 Viatris Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Viatris Children Influenza Vaccine Product Portfolio
  48. 6.8.5 Viatris Recent Developments
  49. 6.9 AstraZeneca
  50. 6.9.1 AstraZeneca Company Information
  51. 6.9.2 AstraZeneca Business Overview
  52. 6.9.3 AstraZeneca Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AstraZeneca Children Influenza Vaccine Product Portfolio
  54. 6.9.5 AstraZeneca Recent Developments
  55. 6.10 GSK
  56. 6.10.1 GSK Company Information
  57. 6.10.2 GSK Business Overview
  58. 6.10.3 GSK Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 GSK Children Influenza Vaccine Product Portfolio
  60. 6.10.5 GSK Recent Developments
  61. 6.11 Jiangsu GDK
  62. 6.11.1 Jiangsu GDK Company Information
  63. 6.11.2 Jiangsu GDK Business Overview
  64. 6.11.3 Jiangsu GDK Children Influenza Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jiangsu GDK Children Influenza Vaccine Product Portfolio
  66. 6.11.5 Jiangsu GDK Recent Developments
7 North America by Country
  1. 7.1 North America Children Influenza Vaccine Sales by Country
  2. 7.1.1 North America Children Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Children Influenza Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Children Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Children Influenza Vaccine Market Size by Country
  6. 7.2.1 North America Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Children Influenza Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Children Influenza Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Children Influenza Vaccine Sales by Country
  2. 8.1.1 Europe Children Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Children Influenza Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Children Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Children Influenza Vaccine Market Size by Country
  6. 8.2.1 Europe Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Children Influenza Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Children Influenza Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Children Influenza Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Children Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Children Influenza Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Children Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Children Influenza Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Children Influenza Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Children Influenza Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Children Influenza Vaccine Sales by Country
  2. 10.1.1 South America Children Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Children Influenza Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Children Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Children Influenza Vaccine Market Size by Country
  6. 10.2.1 South America Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Children Influenza Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Children Influenza Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Children Influenza Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Children Influenza Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Children Influenza Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Children Influenza Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Children Influenza Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Children Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Children Influenza Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Children Influenza Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Children Influenza Vaccine Value Chain Analysis
  2. 12.1.1 Children Influenza Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Children Influenza Vaccine Production Mode & Process
  7. 12.2 Children Influenza Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Children Influenza Vaccine Distributors
  10. 12.2.3 Children Influenza Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst